PMID: 6770410Jan 1, 1980

Evidence for the role of noradrenaline in some effects of quipazine

Psychopharmacology
H FrancèsP Simon

Abstract

In mice, quipazine has shown several behavioral effects: It antagonizes hypothermia induced by a high dose of apomorphine without altering climbing or stereotyped behavior; it antagonizes oxotremorine-induced hypothermia without altering tremors or peripheral signs; and it increases the toxicity of yohimbine. These three responses are considered to be predictive of an antidepressive action; in these three tests the effects of quipazine are inhibited by D,L-propranolol but not by D-propranolol or methysergide. Quipazine, in mice pretreated with pargyline, induced head twitches which were inhibited by methysergide but not by D,L-propranolol. Quipazine, in addition to its well-known serotonergic effects, seems to have beta-adrenergic properties which should be kept in mind when this drug is used as a pharmacological tool and which suggest that the beta-adrenergic system is implied in depression.

References

Feb 1, 1976·The Journal of Pharmacy and Pharmacology·R M QuockE L Chan
Dec 29, 1976·Naunyn-Schmiedeberg's Archives of Pharmacology·J R Walters, R H Roth
Mar 1, 1977·Pharmacology, Biochemistry, and Behavior·J B MalickA Barnett
Nov 23, 1979·European Journal of Pharmacology·M SoutoP Simon
Jan 1, 1978·European Journal of Pharmacology·A J PuechP Simon
Jul 16, 1976·Naunyn-Schmiedeberg's Archives of Pharmacology·M HamonJ Glowinski
Nov 15, 1974·Biochemical Pharmacology·M GrabowskaJ Michaluk
Jun 1, 1972·Life Sciences. Pt. 1: Physiology and Pharmacology·R Rodríguez
Nov 1, 1973·European Journal of Pharmacology·R RodríguezR R Drucker-Colín
Jan 1, 1971·Psychopharmacologia·R Rodríguez, E G Pardo
Jan 1, 1969·European Journal of Pharmacology·E HongE G Pardo
Aug 1, 1963·British Journal of Pharmacology and Chemotherapy·R M QUINTON

Citations

Nov 1, 1981·Pharmacology, Biochemistry, and Behavior·S AhleniusJ L Nilsson
Mar 1, 1982·Pharmacology, Biochemistry, and Behavior·P A Caza, L P Spear
Feb 1, 1985·Pharmacology, Biochemistry, and Behavior·L A Ristine, L P Spear
Jan 1, 1987·Pharmacology & Therapeutics·M F Sugrue
Jun 1, 1987·Behavioural Brain Research·M R PranzatelliS R Snodgrass

Related Concepts

Apokinon
Behavior, Animal
Sansert
Norepinephrine, (+, -)-Isomer
Rexigen
Quinolines
Quipazine Maleate (1: 1)
V-Serp
Stereotyped Behavior
Yohimbin Spiegel

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Systemic Juvenile Idiopathic Arthritis

Systemic juvenile idiopathic arthritis is a rare rheumatic disease that affects children. Symptoms include joint pain, but also fevers and skin rashes. Here is the latest on this disease.

Chromatin Regulation and Circadian Clocks

The circadian clock plays an important role in regulating transcriptional dynamics through changes in chromatin folding and remodelling. Discover the latest research on Chromatin Regulation and Circadian Clocks here.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Pontocerebellar Hypoplasia

Pontocerebellar hypoplasias are a group of neurodegenerative autosomal recessive disorders with prenatal onset, atrophy or hypoplasia of the cerebellum, hypoplasia of the ventral pons, microcephaly, variable neocortical atrophy and severe mental and motor impairments. Here is the latest research on pontocerebellar hypoplasia.

Cell Atlas Along the Gut-Brain Axis

Profiling cells along the gut-brain axis at the single cell level will provide unique information for each cell type, a three-dimensional map of how cell types work together to form tissues, and insights into how changes in the map underlie health and disease of the GI system and its crosstalk with the brain. Disocver the latest research on single cell analysis of the gut-brain axis here.

Chronic Traumatic Encephalopathy

Chronic Traumatic Encephalopathy (CTE) is a progressive degenerative disease that occurs in individuals that suffer repetitive brain trauma. Discover the latest research on traumatic encephalopathy here.